KMSTF
Price
$5.06
Change
-$0.04 (-0.78%)
Updated
Mar 18 closing price
Capitalization
30.34M
ZVRA
Price
$7.23
Change
-$0.02 (-0.28%)
Updated
Apr 24, 04:59 PM (EDT)
Capitalization
399.71M
14 days until earnings call
Ad is loading...

KMSTF vs ZVRA

Header iconKMSTF vs ZVRA Comparison
Open Charts KMSTF vs ZVRABanner chart's image
KADIMASTEM
Price$5.06
Change-$0.04 (-0.78%)
Volume$150
Capitalization30.34M
Zevra Therapeutics
Price$7.23
Change-$0.02 (-0.28%)
Volume$6.44K
Capitalization399.71M
KMSTF vs ZVRA Comparison Chart
Loading...
ZVRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
KMSTF vs. ZVRA commentary
Apr 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KMSTF is a Buy and ZVRA is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 25, 2025
Stock price -- (KMSTF: $5.06 vs. ZVRA: $7.25)
Brand notoriety: KMSTF and ZVRA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: KMSTF: 48% vs. ZVRA: 96%
Market capitalization -- KMSTF: $30.34M vs. ZVRA: $399.71M
KMSTF [@Biotechnology] is valued at $30.34M. ZVRA’s [@Biotechnology] market capitalization is $399.71M. The market cap for tickers in the [@Biotechnology] industry ranges from $266.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.09B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KMSTF’s FA Score shows that 0 FA rating(s) are green whileZVRA’s FA Score has 1 green FA rating(s).

  • KMSTF’s FA Score: 0 green, 5 red.
  • ZVRA’s FA Score: 1 green, 4 red.
According to our system of comparison, ZVRA is a better buy in the long-term than KMSTF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ZVRA’s TA Score shows that 5 TA indicator(s) are bullish.

  • ZVRA’s TA Score: 5 bullish, 6 bearish.

Price Growth

KMSTF (@Biotechnology) experienced а 0.00% price change this week, while ZVRA (@Biotechnology) price change was +2.84% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.94%. For the same industry, the average monthly price growth was -5.37%, and the average quarterly price growth was -12.15%.

Reported Earning Dates

ZVRA is expected to report earnings on Aug 19, 2025.

Industries' Descriptions

@Biotechnology (+7.94% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ZVRA($400M) has a higher market cap than KMSTF($30.3M). ZVRA YTD gains are higher at: -13.070 vs. KMSTF (-20.987). KMSTF has higher annual earnings (EBITDA): -9.53M vs. ZVRA (-76.4M). ZVRA has higher revenues than KMSTF: ZVRA (23.6M) vs KMSTF (0).
KMSTFZVRAKMSTF / ZVRA
Capitalization30.3M400M8%
EBITDA-9.53M-76.4M12%
Gain YTD-20.987-13.070161%
P/E RatioN/AN/A-
Revenue023.6M-
Total CashN/A69.5M-
Total DebtN/A60.3M-
FUNDAMENTALS RATINGS
ZVRA: Fundamental Ratings
ZVRA
OUTLOOK RATING
1..100
19
VALUATION
overvalued / fair valued / undervalued
1..100
84
Overvalued
PROFIT vs RISK RATING
1..100
74
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
52
P/E GROWTH RATING
1..100
18
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ZVRA
RSI
ODDS (%)
Bullish Trend 2 days ago
75%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
80%
Momentum
ODDS (%)
Bullish Trend 2 days ago
80%
MACD
ODDS (%)
Bullish Trend 2 days ago
75%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
79%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
79%
Advances
ODDS (%)
Bullish Trend 8 days ago
81%
Declines
ODDS (%)
Bearish Trend 21 days ago
78%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
89%
Aroon
ODDS (%)
Bearish Trend 2 days ago
84%
View a ticker or compare two or three
Ad is loading...
ZVRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BPTIX172.11N/A
N/A
Baron Partners Institutional
WSMVX22.35N/A
N/A
Wilshire Small Company Value Instl
NMAVX11.24N/A
N/A
Nuance Mid Cap Value Investor
TEMVX7.79N/A
N/A
Nuveen Emerging Markets Eq W
SJGIX26.47N/A
N/A
Steward Large Cap Growth I

KMSTF and

Correlation & Price change

A.I.dvisor indicates that over the last year, KMSTF has been loosely correlated with IRON. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if KMSTF jumps, then IRON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KMSTF
1D Price
Change %
KMSTF100%
N/A
IRON - KMSTF
54%
Loosely correlated
+2.59%
ATBPF - KMSTF
52%
Loosely correlated
N/A
ZVRA - KMSTF
30%
Poorly correlated
-0.82%
ACUT - KMSTF
28%
Poorly correlated
-16.00%
SRZN - KMSTF
28%
Poorly correlated
+0.90%
More

ZVRA and

Correlation & Price change

A.I.dvisor indicates that over the last year, ZVRA has been loosely correlated with CRNX. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if ZVRA jumps, then CRNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ZVRA
1D Price
Change %
ZVRA100%
-0.82%
CRNX - ZVRA
40%
Loosely correlated
+3.55%
KYMR - ZVRA
36%
Loosely correlated
+6.56%
QURE - ZVRA
36%
Loosely correlated
N/A
RVMD - ZVRA
36%
Loosely correlated
+1.57%
ATXS - ZVRA
36%
Loosely correlated
+12.55%
More